James Stice Email & Phone Number
@bridgebio.com
3 phones found area 530
LinkedIn matched
Who is James Stice? Overview
A concise factual answer block for searchers comparing this professional profile.
James Stice is listed as Associate Director at BridgeBio at BBOT, a company with 69 employees, based in San Francisco Bay Area, United States, United States. AeroLeads shows a work email signal at bridgebio.com, phone signal with area code 530, and a matched LinkedIn profile for James Stice.
James Stice previously worked as Associate Director at Bridgebio and Principal Scientist at Bridgebio. James Stice holds Doctor Of Philosophy (Ph.D.), Molecular, Cellular, And Integrative Physiology from University Of California, Davis.
Email format at BBOT
This section adds company-level context without repeating James Stice's masked contact details.
AeroLeads found 1 current-domain work email signal for James Stice. Compare company email patterns before reaching out.
About James Stice
• Molecular pharmacologist with significant expertise in the development, validation and execution of drug screens in the field of oncology.• Adopted cutting edge technologies in the development of innovative, mechanism-based screens, for small molecule therapeutics (i.e. Combinatorial peptide and protein phage display). • Considerable expertise with animal models of breast and prostate tumor growth and metastasis.• Lead an academic-industry partnership that has resulted in the development of a new approach to treat CRPC that is currently moving to the clinic.
Listed skills include Pharmacology, Animal Models, Cell Culture, Real Time Pcr, and 14 others.
James Stice's current company
Company context helps verify the profile and gives searchers a useful next step.
James Stice work experience
A career timeline built from the work history available for this profile.
Associate Director
Current
Principal Scientist
Senior Scientist
Senior Scientist
Scientist
- Developed models of resistance to recently approved FDA drugs in oncology indications
- Conducted CRISPR and RNAi synthetic lethality screens to identify targets engaged during drug-induced senescence
- Analyzed large-scale datasets to prioritize targets involved in resistance
- Performed IND enabling studies for lead drug candidate in multiple oncology indications.
- Provided tactical and strategic guidance to biology subteam (2 RAs) as well as CRO management, while also working extensively at the bench; helped enable team to meet aggressive timelines.
Postdoctoral Scholar
- Lead on 2 separate small molecule inhibitor studies (anti-progestin and CDK 4/6 inhibitor) in collaboration with biotech companies demonstrating compound efficacy in hormone resistant breast and prostate cancer cell.
- Identified and validated new anti-androgens in pre-clinical models of castration resistant prostate cancer through a consortium of academic and biotechnology institutes.
- Elucidated a (the) mechanism by which nuclear receptors inhibit the transcriptional activity of NFκB through the scaffold protein RIP140 and identified and validated small molecule targets in this regulatory axis.
- Defined the protein interactomes for nuclear receptors (A and B) in multiple breast cancer cells using T7 phage display technology and used this information to develop conformation based profiling tools for drug screens.
- Established several collaborations within the Department and laboratory.
- Mentored graduate students.
Graduate Student
- Identified age-related deficits in smooth muscle signaling in menopausal animals, leading to hypertension.
- Determined menopausal effects in the heart, which increased susceptibility to oxidative and DNA damage.
- Published a total of 10 publications with 3 first author publications, 2 first author reviews, and five co-authored papers
Intern
- Studied the role of the protein tyrosine kinase Discoidin Domain Receptor in multiple cancer and its contribution towards increased migration/invasion in cancer models.
- Participated at departmental meetings and collaborated with Physiologic Chemistry and Oncology departments.
James Stice education
Doctor Of Philosophy (Ph.D.), Molecular, Cellular, And Integrative Physiology
Bachelors Of Science, Double Major: Biological Sciences And Psychology
Frequently asked questions about James Stice
Quick answers generated from the profile data available on this page.
What company does James Stice work for?
James Stice works for BBOT.
What is James Stice's role at BBOT?
James Stice is listed as Associate Director at BridgeBio at BBOT.
What is James Stice's email address?
AeroLeads has found 1 work email signal at @bridgebio.com for James Stice at BBOT.
What is James Stice's phone number?
AeroLeads has found 3 phone signal(s) with area code 530 for James Stice at BBOT.
Where is James Stice based?
James Stice is based in San Francisco Bay Area, United States, United States while working with BBOT.
What companies has James Stice worked for?
James Stice has worked for Bbot, Bridgebio, Unity Biotechnology, Oric Pharmaceuticals, and Duke University.
How can I contact James Stice?
You can use AeroLeads to view verified contact signals for James Stice at BBOT, including work email, phone, and LinkedIn data when available.
What schools did James Stice attend?
James Stice holds Doctor Of Philosophy (Ph.D.), Molecular, Cellular, And Integrative Physiology from University Of California, Davis.
What skills is James Stice known for?
James Stice is listed with skills including Pharmacology, Animal Models, Cell Culture, Real Time Pcr, Western Blotting, Immunoprecipitation, Molecular Cloning, and Facs.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial